7.16
-0.03(-0.42%)
Currency In USD
| Previous Close | 7.19 |
| Open | 7.05 |
| Day High | 7.18 |
| Day Low | 7.08 |
| 52-Week High | 9.48 |
| 52-Week Low | 6.29 |
| Volume | 1.04M |
| Average Volume | 2.07M |
| Market Cap | 3.33B |
| PE | -179 |
| EPS | -0.04 |
| Moving Average 50 Days | 7.74 |
| Moving Average 200 Days | 8.17 |
| Change | -0.03 |
If you invested $1000 in Amneal Pharmaceuticals, Inc. (AMRX) since IPO date, it would be worth $477.02 as of May 24, 2025 at a share price of $7.16. Whereas If you bought $1000 worth of Amneal Pharmaceuticals, Inc. (AMRX) shares 5 years ago, it would be worth $1,440.64 as of May 24, 2025 at a share price of $7.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
GlobeNewswire Inc.
May 15, 2025 12:00 PM GMT
Brekiya® becomes the first and only DHE autoinjector that allows patients to self-administer the same medication used in hospitals in a ready-to-use form Product will be available for appropriate patients in the second half of 2025 BRIDGEWATER, N.J.,
Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.
GlobeNewswire Inc.
May 08, 2025 11:00 AM GMT
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation -Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint BRIDGEWATER, N.J., M